Anesthetic-Electrophysiologic Interactions: How Sedatives Shape Cardiac Conduction and Arrhythmia Risk
Hadrian Hoang-Vu Tran1, Audrey Thu2, Axel Fuertes3
1From the Department of Cardiology, University of Florida College of Medicine, Jacksonville, FL.
Cardiology in Review
|July 29, 2026
Summary
Anesthetic and sedative drugs can affect heart function and increase arrhythmia risk. Understanding these effects is crucial for patient safety during medical procedures and in intensive care settings.
Area of Science:
- Cardiology
- Anesthesiology
- Pharmacology
Background:
- Anesthetic and sedative agents are frequently used in clinical settings.
- Their direct impact on cardiac conduction and arrhythmia risk is often underestimated.
- This review focuses on the electrophysiologic effects of common anesthetic agents.
Purpose of the Study:
- To review evidence linking anesthetic agents to myocardial excitability, autonomic tone, and arrhythmia risk.
- To summarize the distinct electrophysiologic profiles of various anesthetic drugs.
- To highlight clinical manifestations of anesthetic-induced cardiac arrhythmias.
Main Methods:
- Mechanistic, experimental, and clinical evidence synthesis.
- Analysis of anesthetic effects on ion channels (sodium, calcium, potassium, pacemaker currents).
- Evaluation of impact on sympathovagal balance.
Main Results:
- Anesthetics like propofol, dexmedetomidine, volatile anesthetics, ketamine, opioids, benzodiazepines, barbiturates, etomidate, and local anesthetics have unique electrophysiologic profiles.
- These agents can cause bradycardia, AV block, atrial fibrillation, QT prolongation, Torsades de Pointes, and ventricular tachyarrhythmias.
- Arrhythmia risk is elevated in patients with pre-existing heart conditions, channelopathies, or instability.
Conclusions:
- Individualized anesthetic titration using ECG monitoring and hemodynamic markers is recommended.
- Limited evidence exists due to study heterogeneity and lack of standardized protocols.
- Further research is needed for optimal sedation strategies minimizing arrhythmia risk.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.